Get the latest Science News and Discoveries
Novel peptide formulation shows promise of restoring cognitive decline in schizophrenia - EurekAlert
Schizophrenia is a serious mental health disorder linked to the imbalance of chemical neurotransmitters that affect cognitive capabilities. Current therapies against schizophrenia have numerous limitations, largely due to the selective permeability of blood-brain barrier, which necessitates the development of novel strategies. Advancing research, scientists from Japan Advanced Institute of Science and Technology have now developed targeted drug delivery systems using peptide-based nanoparticles, that improved cognitive decline in animal models of schizophrenia.
None
Or read this on Eureka Alert